Literature DB >> 2481524

The regulation of interferon production by aspirin, other inhibitors of the cyclooxygenase pathway and agents influencing calcium channel flux.

T C Cesario, S Yousefi, G Carandang.   

Abstract

Interferon is a family of potent antiviral agents which can activate macrophages, enhance cell surface markers, or influence antibody production. Three major types of human interferon are known to exist and have been designated interferons alpha, beta, and gamma. Because of its unique antiviral properties and its ability to influence the immune response, interferon has long been considered a potential therapeutic intervention in the treatment of infections and possibly neoplastic diseases. Two potential means to utilize interferon might be considered: One method would involve the administration of exogenous interferon, but an alternative might augment natural interferon production. We have been investigating a series of pharmacological agents that might influence its production and action. Since prostaglandins influence the immune response, we have investigated the effect of these cyclic fatty acids and those agents that influence their production on soluble protein mediators of the immune response on interferon. Our studies have focused on the effects of acetylsalicylic acid on the interferon system. We have demonstrated that prostaglandins of the E series can significantly reduce the yields of human interferon gamma, but not alpha (the two species of leukocyte derived interferon). In general, yields of gamma interferon produced by peripheral blood mononuclear cells in the presence of PGE2 (0.1 to 0.01 ugm/ml) were approximately 15% of those produced in the absence of these substances. In contrast, when acetylsalicylic acid (10 ugm/ml) was added to the cultures of peripheral blood mononuclear cells yields of gamma interferon increased more than threefold. When examining the effects of acetylsalicylic acid on human alpha interferon production, we were also to enhance interferon harvests although we could not demonstrate an adverse effect of prostaglandins on the production of these bioactive proteins. Addition of acetylsalicylic acid and prostaglandins simultaneously to our cultures had a negative effect on gamma interferon production, but still was associated with enhanced yields of interferon alpha. In examining how prostaglandins might influence interferon production, we began to study other cellular requirements for lymphokine production including those processes which were calcium dependent. Preliminary studies demonstrated that production of human interferon gamma by peripheral blood mononuclear cells was calcium dependent, but production of human interferon alpha was not. Thus, almost all agents studied that influenced calcium dependent intracellular processes influenced the titer of human interferon gamma produced, but not that of human interferon alpha. In examining this phenomenon more closely we noted the calcium channel flux was critical to the production of interferon gamma, hence agents enhancing channel flux(Bay K 8644) increased the production of human interferon gamma, but agents diminishing channel flux (specifically) channel blockers diminished production of this interferon species. These effects depended on the nature of the specific inducing agent. We are now examining the relationship of our observations with calcium to our earlier work with acetylsalicylic acid.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481524      PMCID: PMC1807783     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


  14 in total

Review 1.  The calcium messenger system (2).

Authors:  H Rasmussen
Journal:  N Engl J Med       Date:  1986-05-01       Impact factor: 91.245

2.  Enhancement by carprofen or indomethacin of interferon induction by 10-carboxymethyl-9-acridanone in murine cell cultures.

Authors:  E Storch; H Kirchner; K Hüller; M G Martinotti; D Gemsa
Journal:  J Gen Virol       Date:  1986-06       Impact factor: 3.891

3.  Diminished antiviral effect of human interferon in the presence of therapeutic concentrations of antineoplastic agents.

Authors:  T C Cesario; L M Slater
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

4.  Human immune interferon: induction in lymphoid cells by a calcium ionophore.

Authors:  F Dianzani; T M Monahan; J Georgiades; J B Alperin
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

5.  Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels.

Authors:  M Schramm; G Thomas; R Towart; G Franckowiak
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

6.  Role of calcium in gamma interferon induction: inhibition by calcium entry blockers.

Authors:  F Dianzani; M R Capobianchi; J Facchini
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

7.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.

Authors:  G H Reem; N H Yeh
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

8.  Effect of antineoplastic agents on gamma-interferon production in human peripheral blood mononuclear cells.

Authors:  T C Cesario; L M Slater; H S Kaplan; S Gupta; G J Gorse
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

9.  Influence of prostaglandin E2 and indomethacin on interferon-gamma production by cultured peripheral blood leukocytes of multiple sclerosis patients and healthy donors.

Authors:  G Vervliet; H Deckmyn; H Carton; A Billiau
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

Review 10.  Interferon-gamma, the activated macrophage, and host defense against microbial challenge.

Authors:  H W Murray
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

View more
  8 in total

1.  Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen.

Authors:  M Bakhiet; L-Y Yu; V Ozenci; A Khan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Relative potencies of metal ions on transmitter release at mouse motor nerve terminals.

Authors:  V A Porter; D Wray
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

3.  Aspirin and risk of fatal colon cancer.

Authors:  M Odeh
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

4.  Acetylsalicylic acid has no effects on various isolated immune cells in vitro.

Authors:  G Uhlenbruck; H Lötzerich; J Bernhardt; K Rogalla
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

5.  The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3.

Authors:  D R Haynes; M W Whitehouse; B Vernon-Roberts
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

6.  Influence of acetylsalicylic acid on a Listeria monocytogenes infection.

Authors:  S Hockertz; I Paulini; K Rogalla; T Schettler
Journal:  Agents Actions       Date:  1993-09

Review 7.  Interferon-inducer antivirals: Potential candidates to combat COVID-19.

Authors:  Ashkan Bagheri; Seyed Mohammad Iman Moezzi; Pouria Mosaddeghi; Sadra Nadimi Parashkouhi; Seyed Mostafa Fazel Hoseini; Fatemeh Badakhshan; Manica Negahdaripour
Journal:  Int Immunopharmacol       Date:  2020-12-01       Impact factor: 5.714

8.  Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC).

Authors:  M Jäpel; H Lötzerich; K Rogalla
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.